Special Issue "Multifunctional Nanoparticles for Targeted Delivery and Cancer Therapeutic"

A special issue of Nanomaterials (ISSN 2079-4991).

Deadline for manuscript submissions: 31 March 2021.

Special Issue Editor

Dr. Wafa Al-Jamal
Guest Editor
Nanomedicine and Drug Delivery, School of Pharmacy, Queen’s University Belfast, Belfast, UK
Interests: prostate cancer; nanomedicine; chemotherapy; gene therapy; active targeting; prostate cancer marker; cancer imaging
Special Issues and Collections in MDPI journals

Special Issue Information

Dear colleagues,

Many challenges exist in chemotherapy, especially regarding the delivery of an effective dose to the target site whilst reducing systemic toxicity. However, most anticancer drugs cannot differentiate between cancer cells and normal cells, leading to toxic side effects. The development of targeted systems offers great promise in cancer diagnosis and therapy, both in clinical applications and in pharmaceutical research. To this end, drug delivery, biosensors for diagnosis, and the treatment of diseases have been widely investigated using multifunctional nanoparticles, including through use of metals, liposomes, carbon-based nanostructures, dendrimers, and polymeric nanoparticles.

I would like to invite authors to contribute original research or comprehensive review articles covering the most recent progress and new developments in the design, preparation, characterisation, and application of multifunctional nanoparticles for highly efficient targeted therapies for cancer treatment. This Special Issue of Nanomaterials will collect original high-quality research papers focused on the most recent advances and comprehensive reviews addressing state-of-the-art topics in the field of various multifunctional nanoparticles for current and future anticancer applications. 

Dr. Wafa Al-Jamal
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • cancer
  • chemotherapy
  • active targeting
  • nanocarriers (e.g., liposomes, exosomes, polymeric, metallic nanoparticles, etc.)
  • targeted therapy
  • smart delivery systems
  • theranostics
  • magnetic targeting
  • combinatory treatment

Published Papers

This special issue is now open for submission.
Back to TopTop